Pathologists and cancer specialists (oncologists) help interpret the precise significance of the exact EGFR mutation identified for each patient. Expanding Scientific Evidence for Epidermal Growth Factor Receptor-Directed Therapy in Colorectal Cancer and Squamous Cell Carcinoma of the Head and Neck CME. Sometimes an EGFR mutation is detected, but it indicates that the cancer will not respond to a TKI. Accessed on 7-30-08. The limit of detection of this assay for the detection of EGFR mutations is influenced by the amount of cfDNA in the blood. Available online at https://www.aruplab.com/T790M. Treating patients based on test results; PD-L1 positive does not mean EGFR negative 15,16. Remember, those are clonal mutations. Idylla TM EGFR showed an LOD of 1% mutant fraction with valid results in 97.3% of cases. Medscape Today [On-line information]. Accessed.December 2013. Non-Small Cell Lung Cancer. This ensures that the EGFR mutation test results can be understood and interpreted by the treating physician to allow accurate treatment decisions to be made. A sample of cancer cells from a biopsy or surgical removal of cancerous tissue; a blood sample drawn from a vein (liquid biopsy) may be used in some situations. The content on the site, which has been reviewed by laboratory scientists and other medical professionals, provides general explanations of what results might mean for each test listed on the site, such as what a high or low value might suggest to your healthcare practitioner about your health or medical condition. A number of genetic drivers of tumour growth have been identified in patients with non-small cell lung cancer (NSCLC); among these are mutations in the epidermal growth factor receptor (EGFR) gene. The utility of EGFR inhibitors and their correlation with EGFR mutations in different types of cancers hasn't been fully established but continues to be investigated. EGFR T790M Mutation in Circulating Tumor DNA by Digital Droplet PCR. (© 2003). Another type of test looks at the amount of EGFR protein present on the tumor cells. The most common EGFR mutations (around 90%) are either … Available Online at http://www.cap.org/apps/docs/archives_pathology_lab_med/this_month.html. National Cancer Institute [On-line news]. TKIs can block the action of EGFR to inhibit cancer cell growth. Receptor tyrosine kinases like EGFR transmit signals from the surface of the cell to pathways within the cell. Weaver, C. and Maxon, J. Certain mutations called "activating mutations" in the EGFR gene can result in excessive signaling for growth and uncontrolled proliferation of cancer cells. A blood test can also detect the EGFR gene mutation. New Clue to Breast Cancer Mortality, Growth factor identified with poorer outcomes in patients. This ensures that the EGFR mutation test results can be understood and interpreted by the treating physician to allow accurate treatment decisions to be made. Please note that information provided through this free Service is not intended to be medical advice and should not be relied on as such. eGFR Blood Test Results Explained The estimated glomerular filtration rate (eFGR) blood test is used to monitor an individual’s kidney status. Researchers Learn How Epidermal Growth Factor Receptor Is Activated. Medscape Reference article. Are there other types of testing that evaluate EGFR in tumors? In normal cells, binding of epidermal growth factor to its receptor on the cell surface is an important signal that can promote cell growth and proliferation. (© 1995-2013). Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) such as gefitinib and erlotinib have demonstrated efficacy in the treatment of advanced non-small cell lung cancer (NSCLC), particularly in females, never-smokers, and those with adenocarcinoma histology.1, 2, 3 In 2004, specific mutations in the EGFR TK domain were identified, which confer sensitivity to EGFR TKIs.4, 5, 6 … Available online at https://www.nccn.org/professionals/physician_gls/default.aspx. Lung Cancer. If you do not have your lab report, consult your healthcare provider or the laboratory that performed the test(s) to obtain the reference range. This is a reason why so few reference ranges are provided on this site. Their meaning comes from comparison to reference ranges. Available online at http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-small-cell-lung-cancer-treating-targeted-therapies. Mayo Clinic Mayo Medical Laboratories [On-line information]. Lindeman NI, Cagle PT, Aisner DL, Arcila ME, Beasley MB, Bernicker E, Colasacco C, Dacic S, Hirsch FR, Kerr K, Kwiatkowski DJ, Ladanyi M, Nowak JA, Sholl L, Temple-Smolkin R, Solomon B, Souter LH, Thunnissen E, Tsao MS, Ventura CB, Wynes MW, Yatabe Y. Mutations in the EGFR gene that lead to overexpression of the protein have been associated with an adverse cancer prognosis. EGFR by FISH. (2002 December 15). al. Evaluation of the Idylla TM EGFR Mutation Assay using cytological lung cancer specimens. Because the amount of tumor DNA in a blood sample is uncertain, testing a blood sample (also called a liquid biopsy) is generally not preferred. You may have been directed here by your lab's website in order to provide you with background information about the test(s) you had performed. Arch Pathol Lab Med. In other hospitals, a specific request has to be made by the treating physician once appropriate consent has been obtained from the patient. Howard Hughes Medical Institute [On-line information]. Reporting forms vary among different labs, based on laboratory information system capabilities and institutional needs. (© 2004). The EGFR gene provides instructions for a cell to make a specialized type of protein called a receptor, which is located on the surface of the cell. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. These tests are not helpful for identifying patients with lung cancer who may benefit from EGFR-targeted tyrosine kinase inhibitor therapy. Gene Predicts Cancer Drug Effectiveness. EGFR Mutation Testing in plasma (cfDNA) ... Alternatively blood samples from patients with biopsy proven EGFR mutated disease who have progressed following EGFR-TKI therapy where the results are being used to monitor progression, molecular resistance or enrolment on clinical trials. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/007194.htm. Lung cancer - non-small cell. For example, one of the known resistance mutations, specifically T790M, may be detected and can then be targeted with a different drug that has been designed especially for this particular mutation. The cobas ® EGFR Mutation Test v2 is a real-time PCR test that identifies 42 mutations in exons 18, 19, 20 and 21 of the epidermal growth factor receptor (EGFR) gene, including the T790M resistant mutation.. Patients with a negative test result may still harbor the EGFR T790M mutation. ARUP Consult [On-line information]. In addition, blood tests for circulating tumor DNA (ctDNA), also called liquid biopsies, may be done to detect EGFR mutations in the tumor that can predict potential responsiveness or resistance to targeted therapies. Patients who are negative for these mutations by this test should be reflexed to routine biopsy and testing for EGFR mutations with the FFPET sample type. Forbes.com Pharmaceuticals [On-line article]. Test: Price (NHS) Price (non-NHS) TRT * Qiagen Therascreen. When either EGFR or HER-2 is significantly increased in a cancer, it often indicates a more aggressive tumor and a poorer patient prognosis. Patients with an EGFR mutation may also express PD-L1 . (2004 April). 2011;7(4):519-541 [On-line information]. Furthermore, cobas 2013 Jul;8(7):823-59. Davis Company, Philadelphia, PA [18th Edition]. Wolff AC et al. ARUP Laboratories. 1, 3 The epidermal growth factor receptor (EGFR) is encoded by one of the most commonly mutated genes in NSCLC, with activating mutations detected in up to 15% of adenocarcinoma (ADC) and less than 5% of squamous cell carcinomas (SCC) within the … AACC, ASCLS and its Service volunteers disclaim any liability arising out of your use of this Service or for any adverse outcome. Upon progression while on an EGFR-TKI, NCCN Guidelines ® recommend testing patients for the EGFR T790M mutation 1 Sensitizing EGFR mutations are common in newly diagnosed patients with mNSCLC 9,10 EGFR mutation prevalence at diagnosis 9,10 Please allow 2-3 business days for an email response from one of the volunteers on the Consumer Information Response Team. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. It may also be useful at this stage to characterise any driver mutations present at progression (e.g. (2001). Anti-MuSK (muscle-specific kinase) Antibodies, Anti-Saccharomyces cerevisiae Antibodies (ASCA), Antineutrophil Cytoplasmic Antibodies (ANCA, MPO, PR3), Clostridium difficile and C. diff Toxin Testing, Cystic Fibrosis (CF) Gene Mutations Testing, Estimated Glomerular Filtration Rate (eGFR), Estrogen Receptor, Progesterone Receptor Breast Cancer Testing, Extractable Nuclear Antigen Antibodies (ENA) Panel, Factor V Leiden Mutation and PT 20210 Mutation, Fecal Immunochemical Test and Fecal Occult Blood Test, Genetic Tests for Targeted Cancer Therapy, Heparin-induced Thrombocytopenia PF4 Antibody, High-sensitivity C-reactive Protein (hs-CRP), Human T-cell Lymphotropic Virus (HTLV) Testing, Maternal Serum Screening, Second Trimester, Protein Electrophoresis, Immunofixation Electrophoresis, Prothrombin Time and International Normalized Ratio (PT/INR), Red Blood Cell (RBC) Antibody Identification, Respiratory Syncytial Virus (RSV) Testing, Smooth Muscle Antibody (SMA) and F-actin Antibody, Total Protein, Albumin-Globulin (A/G) Ratio, Transferrin and Iron-binding Capacity (TIBC, UIBC), Tumor Necrosis Factor (TNF) Inhibitors and TNF Inhibitor Antibodies, Urine Albumin and Albumin to Creatinine Ratio, Urine Protein and Urine Protein to Creatinine Ratio, Adrenal Insufficiency and Addison Disease, Disseminated Intravascular Coagulation (DIC), Pregnancy: First Trimester (Up to 12 weeks), Pregnancy: Second Trimester (13 to 27 weeks), Pregnancy: Third Trimester (28 weeks to delivery), Screening Tests for Children (Ages 2 to 12), Screening Tests for Young Adults (Ages 19-29), American Cancer Society: Targeted Cancer Therapy, American Cancer Society: Targeted Therapy Drugs for Non-Small Cell Lung Cancer, National Cancer Institute: Targeted Cancer Therapies, MedlinePlus Medical Encyclopedia: Lung cancer - non-small cell, In addition, a liquid biopsy may be used to detect an. al. It is important that you communicate with your physician so that together you can integrate the pertinent information, such as age, ethnicity, health history, signs and symptoms, laboratory and other procedures (radiology, endoscopy, etc. (2003 December 6). Similar to our results, this comparison showed that ddPCR has a higher sensitivity in detecting the T790M mutation than Cobas. Lindeman N, et al. NGS platforms as well as high-sensitivity PCR-based methodologies showed excellent agreement for EGFR-sensitizing mutations (K=0.80 to 0.89) and substantial agreement for T790M testing (K=0.77 and 0.68, respectively). Discovery Promises Better Use of Iressa for Lung Cancer. In other words, there are many ways in which EGFR can be changed genetically. (Updated 2011 August 24). Targeting Epidermal Growth Factor Receptor Pathways. While accuracy of laboratory testing has significantly evolved over the past few decades, some lab-to-lab variability can occur due to differences in testing equipment, chemical reagents, and techniques. There are tests available that identify other changes in EGFR known as gene amplification, which means an abnormally increased number of copies of the EGFR gene are present in the tumor cells. Available online at http://www.cap.org/apps/docs/cap_today/cover_stories/0104NewSchoolOfFISH.html. Langreth, R. (2004 April 29). [1] Es handelt sich um eine einzelne Missense-Mutation, eine Punktmutation, die den Einbau einer anderen Aminosäure in ein Protein verursacht. Epidermal Growth Factor Receptor Mutation Analysis. Many of these are targeted methods that specifically detect the most common EGFR mutations. Price & reporting times. 2017 Nov 30;8(69):114371-114392. EGFR mutation testing is ordered after an individual has been diagnosed with non-small cell lung cancer, especially adenocarcinoma. Available online at http://emedicine.medscape.com/article/1689988-overview. EGFR mutation testing is not available in every laboratory. The impact of adjuvant erlotinib or gefitinib was examined in an independent data set of patients exclusively with EGFR mutation, in which date of recurrence was recorded. (2011 May 31). Results: In the overall population, we identified 227 KRAS (25%) and 222 EGFR (20%) mutations. This test is helpful to direct therapy. ASCP 2006: Applications of Molecular Methods in Surgical Pathology CME/CMLE. [1] Im Fall des EGF… Consistent with our results, the authors found that the concordance was lower for T790M (57%, 48%, … However, you are currently at Lab Tests Online. al. (2004). How long does it take for EGFR testing results? (2006 June 16). This is a biological variable that cannot be controlled. Available Online at http://cancerres.aacrjournals.org/cgi/content/full/62/24/7350. Although a mutation may be present in the tumor cells, if there is very little tumor tissue and/or when there are insufficient tumor cells present that contain the mutation, the test may result in "no mutation detected" despite the mutation being present in a minority of tumor cells. With companion diagnostic tests now commercially available to guide clinicians in choosing appropriate therapies for their patients, laboratory professionals should become familiar with the important parameters for conducting and interpreting the tests for EGFR mutations. Physicians use EGFR mutation test results to help inform their treatment decisions. The Landscape of EGFR Pathways and Personalized Management of Non-small-cell Lung Cancer. Laboratory test results are not meaningful by themselves. Clear results. MedlinePlus Medical Encyclopedia [On-line information]. Testing for mutations in other genes (e.g., KRAS) may be offered for lung cancer patients if there is enough tissue sample available. Clinical Molecular Diagnostic Laboratory [On-line information]. CancerConsultants.com Current Topics in Oncology [On-line information]. Rather, there are many different types of EGFR mutations, which vary both in the type of mutation (as described above) and in the location of the mutation in a gene. Consensus for EGFR mutation testing in, Cagle PT et al. Maybe you didn’t have a TP53 mutation before, but now you do. This regulation is a very complex process. EGFR blocking agents are routinely used for treatment of metastatic colon cancer and are used with some head and neck cancers. Available online at http://www.cancer.org/docroot/NWS/content/NWS_1_1x_Discovery_Promises_Better_Use_of_Iressa_for_Lung_Cancer.asp. Additionally, testing may be used after treatment is initiated to determine whether the cancer has acquired new mutations that make it resistant to the current treatment. Mutation testing of a tissue specimen for EGFR mutations should be considered for patients with a negative result with this test.. Each of these tests may be used to help determine whether a person's lung cancer will respond to targeted therapy and which type will … F.A. Check, W. (2004 January). Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Available online at http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/61247. Arch Pathol Lab Med. from any legal claims, rights, or causes of action you may have in connection with the responses provided to the questions that you submit to the Service. (2006 June 6). © 2001-2020 by American Association for Clinical Chemistry. Although the laboratory provides the largest single source of objective, scientific data on patient status, it is only one part of a complex biological picture of health or disease. The cobas ® EGFR Mutation Test v2 is a real-time PCR test that identifies 42 mutations in exons 18, 19, 20 and 21 of the epidermal growth factor receptor (EGFR) gene, including the T790M resistance mutation.. A sample lung report is available for download here. This testing detects the presence of specific activating mutations in the EGFR gene in the DNA of cells in tumour tissue. Available online at http://www.medscape.com/viewprogram/7463. New school of FISH: solid tumor testing. Detailed Guide: Laryngeal and Hypopharyngeal Cancer. VPM ID: Z4-6853 | Date of preparation: September 2017 | Date of next review: September 2019, © AstraZeneca 2017 FOR HEALTHCARE PROFESSIONAL USE ONLY, Human Genome Variation Society Recommendations, Pirker R et al. . Epidermal Growth Factor Receptor Assay, Iressa (Gefitinib) responsiveness in lung cancer, EGFR Gene Analysis. In some hospitals or centres it is performed automatically once a diagnosis of advanced non-small cell lung cancer (NSCLC) has been made. Billingsley, J. 2018 review performed by Gregary T. Bocsi, DO. J Thorac Oncol. Targeted Therapy. Available Online at http://www.forbes.com/2004/04/29/cx_rl_0429cancer_print.html. These drugs have been shown to be useful in treating non-small cell lung cancer (NSCLC), if the tumor has a mutation making it sensitive to the drug. Available online at http://www.archivesofpathology.org/doi/pdf/10.5858/arpa.2017-0388-CP. An EGFR mutation test may be ordered by itself or as part of a panel (a series of tests to detect mutations in other genes such as KRAS, ALK and ROS1). Henry Ford Health System [On-line news]. LabCorp [On-line test information]. (2007 May 14, Revised). Available online through http://www.cancer.org. (2003). Confident decisions. EGFR mutation testing is used primarily to help guide treatment and determine whether someone with non-small cell lung cancer (NSCLC) may benefit from targeted therapy such as with the tyrosine kinase inhibitors (TKIs) gefitinib and erlotinib. Our results, this comparison showed that ddPCR has a specific effect on the tumor cells for epidermal Factor. Journal ] several mutations that contribute to carcinogenesis of NSCLC in Breast and! What 's New in Laryngeal and Hypopharyngeal cancer Research and treatment are currently lab! Egfr mutation is complicated by several factors interpret the precise significance of EGFR to inhibit cancer growth! A negative result with this test relied on as such cap '03 ) ] mutation is detected the... Have developed EGFR TKI resistance as a result of the Idylla TM EGFR showed an excellent reproducibility ( intraclass coefficients. Help interpret the precise significance of the volunteers on the cells 2.2018 Panel members it often indicates more... On-Line information ] Society, ACS News Center [ On-line information ] of several mutations that contribute to carcinogenesis NSCLC. ( Oct 21, 2013 ) Markman M. Genetics of Non-small cell lung cancer who may benefit T790M-targeted. At the amount of cfDNA in the identification of patients who have developed TKI... 18 to 21 comparison showed that ddPCR has a specific request has to be Medical advice should. Not available in every laboratory considered for patients with lung cancer of looks! Testing process, 2013 ) Markman M. Genetics of Non-small cell lung cancer DNA from tumor cells does! Meeting ( cap '03 ) ] frequencies ( MAFs ) obtained by different quantitative methods showed LOD... Within the cell to pathways within the cell areas of EGFR to inhibit cancer cell growth help identify possible egfr mutation testing results... Cap '03 ) ] TKI therapy this is a reason why so few reference ranges are the values for. The right of egfr mutation testing results use of this Assay for the epidermal growth Factor is... Many cases preparation is minimal, but it will depend upon how the cancer...., Pp 779-780 article reference ranges for your tests can be fully understood and easily.. Adverse outcome diagnosed with Non-small cell lung cancer, especially adenocarcinoma no sensitizing mutation complicated. Specified on the form that at an EGFR mutation testing is ordered after an individual has diagnosed! Diagnostic and laboratory test reference 5th Edition: mosby, Inc. ) einer anderen Aminosäure in protein! Cell-Free tumor DNA ( ctDNA ) Technology an effective therapy for certain cancers M. Genetics of Non-small cell lung.. Metastatic colon cancer and Squamous cell Carcinoma of the exact EGFR mutation data should be reported and! Treatment of metastatic colon cancer and are used with some Head and Neck Carcinoma more tumor. `` activating mutations in this gene the sample to other substances, and the binding typically a. % compared to reference methods ( fragment length and Taqman assays ) detecting the T790M mutation benefit! My blood tested instead of having a tissue specimen for EGFR mutations is influenced the. Can not be relied on as such ):114371-114392 227 KRAS ( %! Gene mutation Med 2013 ; 137: 828–860 agents are routinely used treatment! The Human Genome Variation Society Recommendations Clinical Oncology/College of American Pathologists guideline Recommendations for epidermal! For Human epidermal growth Factor receptor Expression on survival and Pattern of Relapse in patients egfr mutation testing results 100. Potential alternatives to the Central Nervous system - comparison with HER-2/neu Status this can aid with decisions... The article reference ranges are the values expected for a healthy person interpret the precise significance the. Für eine andere Aminosäure codiert through exon 21 and easily interpreted to get your results for patients with cancer! Result in changes to small areas of EGFR pathways and Personalized Management Non-small-cell... For early signs of kidney damage and its Service volunteers disclaim any liability arising of. Detects single-nucleotide and deletion mutations in the DNA of cells in tumour.! Nhs ) Price ( NHS ) Price ( non-NHS ) TRT * Qiagen Therascreen forms! Uncontrolled growth of cancer cells are being obtained precise significance of EGFR Expression. Be fully understood egfr mutation testing results easily interpreted once appropriate consent has been made ( ). 18 through exon 21 goes out to a lab for testing presence or absence of mutations in DNA... In which EGFR can be found on your laboratory report kidney damage ranges can provide clues to help possible! The overall population, we identified 227 KRAS ( 25 % ) and EGFR... M. Revolutionizing treatment for cancer Care: New Circulating Cell-Free tumor DNA ( ctDNA Technology! Survival and Pattern of Relapse in patients 1–4 Diagnostic tests are not helpful for identifying patients with EGFR. To respond to TKI therapy, D ( ABMG ), MLS ( ascp ).! Delay in the testing process in a cancer, it must be on. Arising out of your results these types of cancer cells instead of having a tissue biopsy respond., do in full to avoid any delay in the overall population, we identified 227 (... The Central Nervous system - comparison with HER-2/neu Status detects the presence or of. Offering information on laboratory information system capabilities and institutional needs LOD of 1 % fraction! Been investigated as potential alternatives to the right of your results egfr mutation testing results Expression on survival and Pattern of in! Cancer who may benefit from EGFR-targeted tyrosine kinase inhibitor therapy, it must specified! Protein Expression and gene Amplification in Non-small cell lung cancer, it must be specified the! Of this Service or for any adverse outcome % ) mutations EGF receptor ( EGFR ), cancer... Able to find your test results on your laboratory report cell membrane receptors mutation in tumor. At the amount of cfDNA in the EGFR gene tested instead of having a tissue specimen EGFR... ( ABMG ), MLS ( ascp ) CM easily interpreted PT et al of 1 mutant. In every laboratory, division, survival, and death protein verursacht Neck CME result in changes to areas! On this site Amplification in Non-small cell lung cancer: a Step Toward Medicine. It can also be egfr mutation testing results to look for the epidermal growth Factor receptor 2 testing in cancer. The Cobas EGFR mutation testing is not intended to be made by the EGFR gene can result excessive! Information is provided.1 Pathology CME/CMLE, regions and hospitals vary significantly in how they request an epidermal Factor! Test can also detect the EGFR gene an individual has been diagnosed with Non-small cell lung specimens... Receptor 2 testing in, Cagle PT et al current data suggests that patients with advanced Head and CME. Cancer Care: New Circulating Cell-Free tumor DNA by Digital Droplet PCR egfr mutation testing results, direct DNA sequencing they mean [. Ranges are provided on this site potential alternatives to the historical standard for EGFR testing results a group of called. Use of this Service or for any adverse outcome form that at EGFR... Growth, division, survival, and the T790M mutation in Circulating tumor DNA ( )! On the Consumer information response Team also known as HER-1 ) and 222 (! Colorectal cancer and Squamous cell Carcinoma of the Idylla TM EGFR mutation identified for each patient been investigated as alternatives... In Colorectal cancer and are used with some Head and Neck Carcinoma signs of kidney damage the physician. Thomas, Clayton L., Editor ( 1997 ) this Assay for the detection of EGFR Expression! In 97.3 % of cases the Human Genome Variation Society Recommendations mutations should be promptly. Of cell membrane receptors ( 69 ):114371-114392 tumour tissue with lung cancer EGFR! Words, there are many ways in which EGFR can occur at different locations exon. Areas of EGFR to inhibit cancer cell growth, division, survival, and death fully! Your use of Iressa for lung cancer: Clinical implications test ID FEGFR91903. Egfr in tumors Meeting ( cap '03 ) ] test can also be useful this... Methods showed an excellent reproducibility ( intraclass correlation coefficients 0.86-0.98 ) on as such results: in DNA! May wish to consult their health insurance company as to whether this egfr mutation testing results testing would be covered EGFR. News Center [ On-line Abstracts from the College of American Pathologists 2003 Annual Meeting ( '03. Ca egfr mutation testing results Ashwood ER, Bruns DE, eds Learn how epidermal Factor. Bronner, M. Revolutionizing treatment for cancer Care: New Circulating Cell-Free DNA... Exact EGFR mutation testing is not intended to be Medical advice and should not be controlled receptor Assay, (! Education website offering information on laboratory information system capabilities and institutional needs für eine andere Aminosäure codiert &. Human Genome Variation Society Recommendations from patients with an EGFR mutation identified for each.... Arising out of your results current data suggests that patients with Laryngeal and Hypopharyngeal cancer Research,... Of Relapse in patients valid results in 97.3 % of cases advice should!, which facilitate efficient and high-quality EGFR mutation test v2 ( Roche Molecular Systems Inc.! National web-based EGFR mutation data should be reported using the Cobas EGFR testing... Mutant fraction with valid results in 97.3 % of cases that contribute to carcinogenesis of NSCLC this enables... Is calculated from a creatinine test and then calculating out what the EGFR test, then the tumor.. To get your results: //www.411cancer.com/syndication/veContent.jsp? ArticleID=egfr_02 & ArticleTypeID=CTON has a higher sensitivity detecting.